By
MikeH on
April 16, 2013
When exactly the Animas Vibe integrated insulin pump and continuous glucose monitor (CGM) hits the U.S. market is now up to the FDA.
Almost two years after the Animas Vibe hit the market in Europe, this Monday Johnson & Johnson submitted the pump to the U.S. regulatory agency. The company publicly announced the submission during their first quarter earnings call early this morning.
Our Diabetes Community has been anxiously awaiting this news since October, when…
Read more »
By
MikeH on
April 12, 2013
Everyone wants to know what the patient community is thinking these days. The explosion of social media and patient advocacy has fueled the desire for Pharma, device companies, health organizations and insurers to seek out our perspective and input — which is a wonderful development!
This is happening not just in diabetes, but across the broader spectrum of health conditions. But the Diabetes Online Community (DOC) does stand out, as it seems to be the…
Read more »
By
MikeH on
March 19, 2013
Snuggled up in my bed under the warm covers, all I want to do is keep my eyes closed.
But, no. My darn insulin pump and continuous glucose monitor (CGM) just won’t shut up and let me sleep. Both vibrate and beep incessantly, reminding me that I’m low and nagging me to wake up and do something about it.
Neither device can actually intervene or do anything to prevent these lows (or highs) from happening.…
Read more »
Anyone going on a brand spanking new insulin pump is probably filled with anticipation and excitement, but there’s always a little bit of trepidation when it comes to a new piece of medical technology. Will it meet my needs? Will I like using it? Most importantly: will it work? The fear of potential problems like motor error, malfunctioning buttons, and occlusions can throw a wrench in anyone’s pumping anticipation.
Apparently, those wrenches have been flying…
Read more »
By
MikeH on
January 8, 2013
In the world of diabetes devices, company execs, PR pros, sales reps and even doctors are often vague about when new products will hit the market and be available for us people with diabetes. They tout new tools “coming soon” without any specificity as to when a product might actually be available. And on message boards frequented by patients, rumors can fly.
After an exciting year of new diabetes product approvals in 2012, we wanted…
Read more »
